volume 2, issue 8, PS558-S559 2007
DOI: 10.1097/01.jto.0000283637.19972.88
View full text
|
|
Share

Abstract: who received active treatment lived longer than those who received the best supportive care (NSCLC: 12 vs. 4 months, p=0.015, Figure 1; SCLC: 14 vs. 5 months, p=0.02, Figure 2).There was a similar response to chemotherapy between the elderly and non-elderly patients (NSCLC: p=0.386; SCLC: p=0.172). Conclusion:Even though elderly patients have a poor performance status compared with non elderly patients, chemotherapy improves the overall survival time and response rate in eligible patients.

Search citation statements

Order By: Relevance

Citation Types

0
0
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals